Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
30,184 total articles
Iovance Biotherapeutics shares climbed 32% after the company disclosed encouraging early results from a pilot study of lifileucel in advanced undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS). The trial, led by Memorial Sloan Kettering Cancer Center, reported a 50% objective response rate among the first six evalua…
Neuberger Berman is evaluating an expansion of its insurance capabilities that could include establishing an entity able to purchase life insurance assets, according to people familiar with the matter. The review is exploratory, with no certainty the firm will pursue the plan. The move reflects a wider trend of asset managers seeking fee income and…
Wolf Research screened the S&P 500 Dividend Aristocrats to surface 10 companies that combine solid dividend-growth characteristics with financial stability. The firm filtered for above-market dividend growth, second-quintile yields or steady repurchase programs and excluded firms showing high leverage or signals of dividend stress. The selected fir…
Alcoa said it intends to sell 10 closed or curtailed facilities to operators in the data centre industry, with the company targeting a first closing by the end of June and potential follow-on sales soon after. The announcement coincided with a 4% increase in the aluminium producer's share price and reflects management's efforts to convert underused…
CarGurus (CARG) shares rose 4% on Thursday as investor fears about artificial intelligence competition in the software arena eased. The gain followed an earlier pullback that occurred after Anthropic emerged as a perceived threat to software companies, prompting scrutiny of CarGurus' expanding software initiatives. Huber Research characterized the …
Colgate-Palmolive has informed a conservative shareholder group it intends to oppose a proposal seeking to eliminate race, gender and sexual orientation from criteria used to identify future board members. The company says the proposal would inappropriately constrain its nominating committee and stresses that diverse perspectives are important to s…
Raymond James upgraded Genuine Parts Company from Outperform to Strong Buy and established a $145 price target based on a sum-of-the-parts analysis tied to the planned split of its Auto and Industrial businesses. The firm argues the market is undervaluing the Auto operations relative to peers, and projects the separation to close by the first quart…
Shares of Reitar Logtech Holdings Limited (NASDAQ:RITR) fell 9% on Tuesday after the company disclosed a non-binding memorandum of understanding for a possible $60 million equity investment. The arrangement, proposed with Equator Capital Management SPC acting for Equator Private Equity Fund SP, would fund Reitar's participation in a consortium seek…
Alcoa Corp is seeking buyers from the data centre sector for 10 of its closed or curtailed aluminium sites, with its CEO saying the company expects the first sale to close by the end of June. The move reflects rising demand for power-adjacent real estate from data centres and raises questions about how AI-driven data centre growth could alter asset…
U.K. equities closed marginally lower on Tuesday, with the United Kingdom 100 index down 0.03% as losses in fixed-line telecommunications, REITs and automobile parts companies weighed on the market. While several mid-cap stocks posted strong gains, a handful of larger declines, including a steep fall in a major landlord, helped push the benchmark s…
Edesa Biotech's stock rose sharply after the company disclosed additional Phase 3 data for paridiprubart that indicate statistically significant reductions in adjusted 28-day mortality across an expanded patient cohort. The dataset covers 278 patients, including those who were and were not on invasive mechanical ventilation, and shows consistent sa…
Spain's benchmark index ended Tuesday's session in negative territory, dragged down by losses in Financial Services & Real Estate, Telecoms & IT and Consumer Services. The IBEX 35 closed down 0.54% in Madrid, even as several large-cap utilities and industrials posted strong gains and hit multi-year or record highs.
Portugal's main equity index, the PSI, closed higher on Tuesday, rising 0.25% to reach a new five-year high. Gains were concentrated in the Utilities, Consumer Goods and Telecoms sectors, with EDP Renovaveis, EDP and Ibersol among the top performers. Banking, postal and energy names finished lower. Commodity prices slipped and major currency pairs …
The AEX index closed higher on Tuesday, rising 0.34% to a fresh record high as stocks in the Healthcare, Technology and Oil & Gas sectors pushed the market up. Market breadth was mixed with slightly more decliners than advancers. Key individual movers included Wolters Kluwer, Magnum Ice Cream and BE Semiconductor Industries on the upside, while ABN…
Italian equities finished marginally lower after the close on Tuesday, with the Investing.com Italy 40 slipping 0.05% in Milan. Sector declines in Financials, Telecoms and Oil & Gas were cited as the primary drags. Notable winners included Ferrari, Lottomatica and Leonardo, while several regional banks led the decliners. Commodity and currency mark…
German equities finished slightly higher on Tuesday, with the DAX up 0.12% at the close as Technology, Utilities and Food & Beverages names provided upward momentum. The MDAX and TecDAX also rose, led by selected rallies in semiconductor and specialty chemical names, while several healthcare and industrial stocks posted notable declines. Market vol…
Sarepta Therapeutics' stock climbed after Chugai Pharmaceutical initiated commercial sales of ELEVIDYS in Japan subsequent to its listing on Japan’s National Health Insurance price list. The launch activates a $40 million milestone payment to Sarepta under its collaboration with Roche. ELEVIDYS is the first gene therapy approved and launched in Jap…
Paris equities finished higher on Tuesday, with the benchmark CAC 40 closing at a new all-time high after modest sector-led advances. Euronext, Stellantis and Renault were among the index leaders, while Safran, BNP Paribas and Herms weighed on the market. The broader SBF 120 registered larger winners in Eramet, Valneva and Technip Energies, even as…
Belgian equities ended higher after the close on Tuesday, with the benchmark BEL 20 index rising 0.43%. Gains were led by the Basic Materials, Utilities and Technology sectors, while market breadth favored rising issues over decliners. Commodity prices and major currency pairs showed modest movements alongside a slight uptick in the dollar index.
Klaviyo's stock climbed 8% after the company announced a strategic collaboration with Google to fuse search, advertising, and messaging capabilities with Klaviyo's customer data and engagement platform. The tie-up includes multiple integrations already available and pilots that bring interactive mobile messaging and AI-driven conversations to consu…
Shares of Keysight Technologies jumped 24% after the company reported first-quarter results with core orders up 22% year-over-year, beat revenue and EPS estimates, and raised its fiscal 2026 adjusted EPS growth framework to more than 20% year-over-year. BofA upgraded the stock to Buy and lifted its price target to $340.
MicroVision Inc. obtained $43 million in senior secured convertible notes in a financing with High Trail Capital that exchanges and adds to its existing secured debt, deferring earlier repayment obligations and providing capital to support integration of assets acquired from Luminar Technologies and Scantinel Photonics.
The OMX Stockholm 30 closed higher on Tuesday, rising 0.76% to reach a fresh all-time high. Strength in Basic Materials, Industrials and Technology propelled the market, with Boliden setting a record, while several large-cap telecom and banking names eased back. Commodity and currency moves were modest, with oil and gold slipping and the dollar ind…
Finnish equities rose at the close of trading on Tuesday, with the OMX Helsinki 25 advancing 0.28% to a new all-time high. Gains were concentrated in Consumer Services, Basic Materials and Industrials, while several individual stocks posted notable moves. Commodity and foreign exchange markets showed modest movement alongside the equity session.
Cadrenal Therapeutics (NASDAQ:CVKD) saw its stock climb 11% after reporting Phase 2 results for CAD-1005 in patients with heparin-induced thrombocytopenia (HIT). The randomized, blinded, placebo-controlled trial in 24 patients showed fewer thrombotic events in the CAD-1005 arm compared with placebo, while the primary endpoint of platelet count reco…
